{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23199848",
  "DateCompleted": {
    "Year": "2013",
    "Month": "02",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2012",
        "Month": "11",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S0140-6736(12)61804-2",
      "S0140-6736(12)61804-2"
    ],
    "Journal": {
      "ISSN": "1474-547X",
      "JournalIssue": {
        "Volume": "381",
        "Issue": "9864",
        "PubDate": {
          "Year": "2013",
          "Month": "Feb",
          "Day": "02"
        }
      },
      "Title": "Lancet (London, England)",
      "ISOAbbreviation": "Lancet"
    },
    "ArticleTitle": "Prescription of physical activity: an undervalued intervention.",
    "Pagination": {
      "StartPage": "356",
      "EndPage": "357",
      "MedlinePgn": "356-7"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Federal University of Pelotas, 96020-220 Pelotas, Rio Grande do Sul, Brazil. prchallal@terra.com.br"
          }
        ],
        "LastName": "Hallal",
        "ForeName": "Pedro C",
        "Initials": "PC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lee",
        "ForeName": "I-Min",
        "Initials": "IM"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Lancet",
    "NlmUniqueID": "2985213R",
    "ISSNLinking": "0140-6736"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Lancet. 2013 Feb 2;381(9864):394-9",
      "PMID": "23199849"
    },
    {
      "RefSource": "Lancet. 2013 May 11;381(9878):1623-4",
      "PMID": "23663945"
    },
    {
      "RefSource": "Lancet. 2013 May 11;381(9878):1623",
      "PMID": "23663946"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "mortality"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Dyslipidemias"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Physical Fitness"
    }
  ]
}